PLSM

424B3 - Pulsenmore Ltd. (0002064764) (Filer)

DENVER, July 13, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- From a transformational merger and corporate restructuring at Twin Vee PowerCats, to encouraging Phase 2 clinical data from Q32 Bio, major oncology financing by Agenus, government-backed AI development at Pulsenmore, shareholder returns from LogProstyle, and new third-party testing validating Xeriant's advanced construction materials, this week's developments demonstrate the diverse catalysts capable of reshaping small-cap growth stories. Twin Vee PowerCats (NASDAQ:VEEE) announced one of the week's most significant corporate restructurings through a definitive agreement that combines a merger with privately held USFM Corpora

6-K - Pulsenmore Ltd. (0002064764) (Filer)

The program is designed to enable Pulsenmore to develop and clinically validate AI applications that improve clinical workflow efficiency and enhance the scalability of the company's home ultrasound platform. RAMAT GAN, Israel, July 13, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in connected home ultrasound technology, today announced that it has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program, established by the Israel Innovation Authority (IIA) and the Ministry of Health. Pulsenmore will receive funding from the IIA as part of a project.The program is designed to accelerate the adoption of breakthrough healthcare AI technolo

EFFECT - Pulsenmore Ltd. (0002064764) (Filer)

D - Pulsenmore Ltd. (0002064764) (Filer)

F-1 - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

RAMAT GAN, Israel, June 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it has entered into a securities purchase agreement with a healthcare-focused institutional investor, for the purchase and sale of 1,562,500 ordinary shares (or pre-funded warrants in lieu thereof) and ordinary warrants to purchase up to 1,562,500 ordinary shares in a private placement at a combined purchase price of $4.80 per ordinary share and accompanying warrant  (or $4.7999 per pre-funded warrant and accompanying ordinary warrant), representing a premium to the Nasdaq Minimum Price under Nasdaq rules. The gross proceeds from the offer

6-K - Pulsenmore Ltd. (0002064764) (Filer)

FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal care across the United StatesRAMAT GAN, Israel, June 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States. Through the collaboration, Ouma Health will incorporate Pulsenmore's FDA-authorized home ultrasou

6-K - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

20-F - Pulsenmore Ltd. (0002064764) (Filer)

Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update OMER, Israel, March 30, 2026  /PRNewswire/ – Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced financial results for the full year ended December 31, 2025.  Full-Year 2025 Financial HighlightsFull year revenue of $12.5 million, representing a 374% increase compared to 2024, including a one-time revenue contribution of $9.6 million related to the GE settlement discussed below.Net loss improved significantly to $5 million, compared to $10 million in 2024.$21.7 million in total liquid assets (including $7 million in cash and cash equ

OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full year 2025 on March 30, 2026 at 8:30 a.m. EST. The Company will host a conference call and webcast to discuss its financial results, business highlights, and recent progress.Conference Call & Webcast DetailsDate: March 30, 2026Time: 8:30 a.m. Eastern Time/ 3:30 p.m. Israel TimeWebcast: https://teams.microsoft.com/meet/3845461353556?p=fcIpXc4mErwEAqo3IrReplay: The meeting will be record

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)